Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA): Implementation of PsOWellTM in PsA

NCT05631223 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05631223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA): Implementation of PsOWellTM in PsA
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2023
Completion date
February 6, 2026
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis